P. Huber-Cantonati

A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma

D. Schuster, M. Tollinger, H. Zwierzina, 2019, Oncogene.

Analogues of Natural Chalcones as Efficient Inhibitors of AKR1C3

D. Schuster, V. Temml, G. Möller, 2022, Metabolites.

Metabolic implication of tigecycline as an efficacious second‐line treatment for sorafenib‐resistant hepatocellular carcinoma

A. Vollmar, H. Zischka, A. Gerbes, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.